GCLM
Glutamate--cysteine ligase regulatory subunit
Also known as: GLCLR, GSH0_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48507
- Gene
- GCLM
- Ensembl
- ENSG00000023909
- Chromosome
- 1
- Canonical length
- 274 aa
- Protein class
- Cancer-related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase, is the first rate limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. Gamma glutamylcysteine synthetase deficiency has been implicated in some forms of hemolytic anemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
Canonical amino-acid sequenceUniProt
274 residues, UniProt reviewed canonical sequence.
>P48507|GCLM
1 MGTDSRAAKA LLARARTLHL QTGNLLNWGR LRKKCPSTHS EELHDCIQKT LNEWSSQINP
61 DLVREFPDVL ECTVSHAVEK INPDEREEMK VSAKLFIVES NSSSSTRSAV DMACSVLGVA
121 QLDSVIIASP PIEDGVNLSL EHLQPYWEEL ENLVQSKKIV AIGTSDLDKT QLEQLYQWAQ
181 VKPNSNQVNL ASCCVMPPDL TAFAKQFDIQ LLTHNDPKEL LSEASFQEAL QESIPDIQAH
241 EWVPLWLLRY SVIVKSRGII KSKGYILQAK RRGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCLM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- liver: 45 nTPM
- duodenum: 18 nTPM
- thyroid gland: 16 nTPM
- skeletal muscle: 15 nTPM
- bone marrow: 14 nTPM
- fallopian tube: 14 nTPM
Single-cell type
- epididymal efferent duct ciliated cells: 454 nCPM
- epididymal clear cells: 308 nCPM
- erythrocyte progenitors: 274 nCPM
- epididymal basal cells: 260 nCPM
- fallopian tube ciliated cells: 216 nCPM
- platelets: 206 nCPM
Immune cell
- memory CD8 T-cell: 3.3 nTPM
- gdT-cell: 2.6 nTPM
- memory CD4 T-cell: 2.5 nTPM
- NK-cell: 2.3 nTPM
- basophil: 2 nTPM
- naive B-cell: 1.9 nTPM
Brain region
- hypothalamus: 20 nTPM
- pons: 19 nTPM
- midbrain: 19 nTPM
- medulla oblongata: 17 nTPM
- white matter: 16 nTPM
- thalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.36
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic mitochondrial changes
- blood vessel diameter maintenance
- cellular response to fibroblast growth factor stimulus
- cellular response to follicle-stimulating hormone stimulus
- cellular response to glucose stimulus
- cellular response to hepatocyte growth factor stimulus
- cellular response to leukemia inhibitory factor
- cellular response to thyroxine stimulus
- cysteine metabolic process
- glutamate metabolic process
- glutathione biosynthetic process
- hepatic stellate cell activation
- negative regulation of extrinsic apoptotic signaling pathway
- negative regulation of neuron apoptotic process
- regulation of mitochondrial depolarization
- response to activity
- response to human chorionic gonadotropin
- response to nitrosative stress
- response to nutrient
- response to oxidative stress
- response to xenobiotic stimulus
Molecular functions
- glutamate-cysteine ligase activity
- protein-containing complex binding
- glutamate-cysteine ligase catalytic subunit binding
- glutamate-cysteine ligase regulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NADP-dependent oxidoreductase domain
- NAD(P)-dependent oxidoreductase domain superfamily
- Aldo/keto reductase family
- Glutamate--cysteine ligase regulatory subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCLM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCLM as an antibody target. Whether an autoantibody or antibody against GCLM could matter depends on whether native GCLM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCLM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCLM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...